|
FAM13A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.24678045665405E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.17029719248762E-11 |
| Normal-vs-Stage2 |
4.21669998917906E-09 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.62891922173003E-12 |
| Stage1-vs-Stage2 |
6.260400E-01 |
| Stage1-vs-Stage3 |
3.890400E-02 |
| Stage1-vs-Stage4 |
8.812700E-04 |
| Stage2-vs-Stage3 |
9.066200E-02 |
| Stage2-vs-Stage4 |
7.122300E-03 |
| Stage3-vs-Stage4 |
2.449400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.16671125485846E-12 |
| Normal-vs-AfricanAmerican |
4.0256999999988E-05 |
| Normal-vs-Asian |
8.03312971697778E-12 |
| Caucasian-vs-AfricanAmerican |
3.026400E-01 |
| Caucasian-vs-Asian |
6.844600E-01 |
| AfricanAmerican-vs-Asian |
4.140600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.47319950577685E-11 |
| Normal-vs-Female |
6.09179373611823E-13 |
| Male-vs-Female |
1.914220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.31663602032495E-12 |
| Normal-vs-Age(41-60Yrs) |
9.09894382061793E-12 |
| Normal-vs-Age(61-80Yrs) |
2.20623519453511E-12 |
| Normal-vs-Age(81-100Yrs) |
3.70610000000049E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.919400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.179800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.884040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.406200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.035800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.787000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.69180000511682E-08 |
| Classical-VS-Follicular |
4.569800E-02 |
| Classical-VS-Other |
2.957600E-01 |
| Classical-VS-Normal |
4.2330583482908E-12 |
| Tall-VS-Follicular |
5.12989994927437E-09 |
| Tall-VS-Other |
7.322200E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.289800E-01 |
| Follicular-VS-Normal |
3.90330001653894E-09 |
| Other-VS-Normal |
1.865850E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18209886323939E-11 |
| Normal-vs-N1 |
2.80886425230165E-14 |
| N0-vs-N1 |
8.962000E-03 |
|
|
